Cargando…
Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
BACKGROUND: A multitarget stool DNA test (MSDT) that showed higher sensitivity but lower specificity than a fecal immunochemical test (FIT) for hemoglobin in one recent study from the US and Canada, is increasingly used for colorectal cancer (CRC) screening, despite its ~20-fold higher costs compare...
Autores principales: | Brenner, Hermann, Chen, Hongda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516775/ https://www.ncbi.nlm.nih.gov/pubmed/28761377 http://dx.doi.org/10.2147/CLEP.S136565 |
Ejemplares similares
-
Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”
por: Ahlquist, David A
Publicado: (2017) -
Population-based colorectal cancer screening: comparison of two fecal occult blood test
por: Zubero, Miren B., et al.
Publicado: (2014) -
Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996) -
Optimization of screening strategies for colorectal cancer based on fecal DNA and occult blood testing
por: Yao, Tingting, et al.
Publicado: (2023) -
Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening
por: Yang, Cuiping, et al.
Publicado: (2020)